Correction
Claudia Fuchs(Medical University of Vienna), Michael Trauner(Medical University of Graz), Marcus Henricsson(University of Gothenburg), Emmanuel D. Dixon(Medical University of Vienna), Hubert Scharnagl(Medical University of Graz), Tatjana Stojaković, Thierry Claudel(Medical University of Vienna), Thomas Reiberger(Harvard University), Veronika Mlitz(Medical University of Vienna), Antonio Molinaro(University of Naples Federico II), Philipp Königshofer(Medical University of Vienna)
Cited by 0
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Multivalent glycoconjugates as anti-pathogenic agents
|Chemical Society Reviews|2012|534
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399